Supernus Pharmaceuticals | SUPN - Market Capitalization


Supernus Pharmaceuticals reported $2.65B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
ANI Pharmaceuticals USD 2.04B 630M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 8.76B 977M Sep/2025
Eisai JPY 1.45T 280.95B Sep/2025
Eli Lilly USD 722.15B 16.64B Sep/2025
Novo Nordisk A/S DKK 1.54T 423.96B Sep/2025
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
United Therapeutics USD 18.96B 6B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026